课题基金 / 基金详情

T-LYMPHOCYTE REGULATED TUMOR CELL KILLING BY NEUTROPHILS

T-LYMPHOCYTE REGULATED TUMOR CELL KILLING BY NEUTROPHILS
T 淋巴细胞调节中性粒细胞杀死肿瘤细胞
批准号:
3169188
负责人:
Richard Weisbart
金额:
$10.14万
依托单位国家:
美国
项目类别:
财政年份:
1981
资助国家:
美国
项目状态:
已结题
起止时间:
1981-07-01 至 1989-01-31

项目摘要

项目成果

Richard Weisbart的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Intercellular communication by lymphocyte hormones, or lymphokines, is instrumental in the regulation of immune responses that maintain host defense against infection, prevent autoreactivity, and provide surveillance against neoplasia. The investigation of lymphokines will increase our understanding of disordered immune regulation and provide new therapeutic agents for many human diseases. The investigation of each lymphokine requires a comprehensive approach including purification to homogeneity, chemical characterization, assessment of biological functions, the production of monospecific antibodies, and gene cloning. Our laboratory has purified to homogeneity a neutrophil migration inhibition factor, (NIF-T), which is a neutrophil activating factor produced by helper T-lymphocytes. This accomplishment establishes the feasibility of achieving the remaining goals. 1. To establish in vitro assay models of neutrophil-mediated cytotoxicity that are both antibody dependent and independent. 2. To determine the effect of NIF-T, a neutrophil activating factor, on neutrophil-mediated tumor cell cytotoxicity. 3. To clone the gene for NIF-T to provide abundant quantities of NIF-T for laboratory and clinical studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting MDM2 with Intracellular Antibodies
Targeting MDM2 with Intracellular Antibodies
MECHANISM OF AUTOANTIBODY ENTRY INTO CELLS AND NUCLEI
T-LYMPHOCYTE REGULATED TUMOR CELL KILLING BY NEUTROPHILS
海外基金